OncoSil Medical Limited (OSL.AX)
AUD 0.01
(-14.29%)
AUD 0.01
(-14.29%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.56 Million | 367.67 Thousand | 231.78 Thousand | 213.07 Thousand | 2.76 Million | 3.62 Million |
| Cost of Revenue | 1.5 Million | 6.86 Million | 6.95 Million | 6.44 Million | 149.28 Thousand | 38.61 Thousand |
| Gross Profit | 55.63 Thousand | -6.49 Million | -6.72 Million | -6.22 Million | 2.61 Million | 3.58 Million |
| Operating Expenses | 12.03 Million | 6.05 Million | 4.68 Million | 5.39 Million | 7.06 Million | 12.37 Million |
| Selling, General and Administrative Expenses | 9.05 Million | 3.2 Million | 2.3 Million | 2.51 Million | 3.33 Million | 6.79 Million |
| Research and Development Expenses | 2.98 Million | 2.85 Million | 2.37 Million | 2.88 Million | 3.72 Million | 5.57 Million |
| Other Expenses | - | 1.15 Million | 692.11 Thousand | 1.12 Million | 2.85 Million | 3.64 Million |
| Cost and Expenses | 13.54 Million | 12.92 Million | 11.64 Million | 11.84 Million | 7.2 Million | 12.41 Million |
| Operating Income | -11.98 Million | -12.55 Million | -11.4 Million | -11.62 Million | -7.2 Million | -12.41 Million |
| Interest Expense | 3944.00 | 10.9 Thousand | 19.62 Thousand | 15.74 Thousand | 11.08 Thousand | - |
| Income Tax Expense | - | -1.09 Million | -831.59 Thousand | -1.07 Million | -2.76 Million | -3.62 Million |
| Earnings before Tax | -11.91 Million | -12.44 Million | -11.55 Million | -11.51 Million | -7.02 Million | -12.19 Million |
| Net Income | -11.91 Million | -11.34 Million | -10.72 Million | -10.43 Million | -4.26 Million | -8.56 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 2.21 Billion | 1.19 Billion | 1.05 Billion | 1.07 Billion | 865.59 Million | 845.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.21 Billion | 1.19 Billion | 1.05 Billion | 1.07 Billion | 865.59 Million | 845.6 Million |
| Gross Margin | 0.04 | -17.66 | -29.02 | -29.23 | 0.95 | 0.99 |
| EBIT Margin | -7.65 | -33.66 | -48.68 | -53.70 | -2.55 | -3.41 |
| Profit Margin | -7.61 | -30.85 | -46.28 | -48.97 | -1.54 | -2.36 |
| EBITDA | -11.97 Million | -11.31 Million | -11.41 Million | -10.5 Million | -6.86 Million | -12.15 Million |
| Earnings Before Tax Margin | -7.66 | -34.14 | -49.22 | -54.57 | -2.61 | -3.42 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 232.93 Thousand | 320.89 Thousand | 87.95 Thousand | 367.67 Thousand | 151.35 Thousand | 216.32 Thousand |
| Cost of Revenue | 2.84 Million | 6.11 Million | 3.31 Million | 6.86 Million | 3.58 Million | 3.28 Million |
| Gross Profit | -2.61 Million | -5.79 Million | -3.22 Million | -6.49 Million | -3.42 Million | -3.06 Million |
| Operating Expenses | 4.03 Million | 7.47 Million | 3.39 Million | 6.05 Million | 2.78 Million | 3.27 Million |
| Selling, General and Administrative Expenses | 2.64 Million | - | 1.8 Million | - | 1.68 Million | 1.51 Million |
| Research and Development Expenses | 1.39 Million | - | 1.59 Million | - | 1.09 Million | 1.75 Million |
| Other Expenses | - | - | - | 1.15 Million | - | - |
| Cost and Expenses | 6.88 Million | 13.58 Million | 6.7 Million | 12.92 Million | 6.36 Million | 6.55 Million |
| Operating Income | -6.64 Million | -13.26 Million | -6.61 Million | -12.55 Million | -6.21 Million | -6.33 Million |
| Interest Expense | - | 563.00 | 5229.00 | 10.9 Thousand | 4134.00 | 6766.00 |
| Income Tax Expense | -581.71 Thousand | -1.13 Million | -552.76 Thousand | -1.09 Million | -506.48 Thousand | -593.26 Thousand |
| Earnings before Tax | -6.94 Million | -13.5 Million | -6.56 Million | -12.44 Million | -6.19 Million | -6.24 Million |
| Net Income | -6.35 Million | -12.37 Million | -6.01 Million | -11.34 Million | -5.69 Million | -5.65 Million |
| Earnings Per Share Basic | -0.00 | - | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 2.11 Billion | 2.21 Billion | 2.09 Billion | 1.19 Billion | 1.38 Billion | 1.29 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.11 Billion | 2.21 Billion | 2.09 Billion | 1.19 Billion | 1.38 Billion | 1.29 Billion |
| Gross Margin | -11.21 | -18.06 | -36.66 | -17.66 | -22.66 | -14.17 |
| EBIT Margin | -28.55 | - | -74.28 | - | -40.50 | -28.88 |
| Profit Margin | -27.30 | -38.57 | -68.41 | -30.85 | -37.60 | -26.13 |
| EBITDA | -6.64 Million | - | -6.53 Million | - | -6.12 Million | -6.24 Million |
| Earnings Before Tax Margin | -28.55 | -41.34 | -75.24 | -34.14 | -41.07 | -29.30 |
558
GPMTF
2845
MIS
KTN
LT